Home › Research › Biomarkers
Blood phosphorylated tau for the diagnosis of Alzheimer's disease: a systematic review and meta-analysis
Joseph Therriault, Henrik Zetterberg, Kaj Blennow, Pedro Rosa-Neto, et al.. The Lancet Neurology, 2025-09
Topic: Amyloid, tau and blood-test diagnosis
Plain-language summary
This large review pooled 113 studies (nearly 30,000 people) comparing different forms of blood phosphorylated tau for detecting Alzheimer's pathology. p-tau217 was clearly the best-performing marker, correctly identifying disease pathology about 88% of the time, outperforming other tau variants like p-tau181. The authors also flagged that most existing studies have methodological weaknesses that could inflate reported accuracy.
What this study adds
Evidence grade: Moderate
This is a pooled review of 29,625 participants. Across 113 studies, blood p-tau217 identified Alzheimer's pathology about 88% of the time and outperformed other tau variants like p-tau181. Its stated limit: About 90% of the pooled studies were rated high risk of bias due to lack of predefined thresholds, per the authors' own assessment.
Taken from this record’s own fields, not from reading the paper. The grade is assigned from the abstract’s wording; what that means.
Cite this study APA, Vancouver, BibTeX · download .bib or .ris
APA 7th
Therriault, J., Zetterberg, H., Blennow, K., Rosa-Neto, P., et al. (2025). Blood phosphorylated tau for the diagnosis of Alzheimer's disease: a systematic review and meta-analysis. The Lancet Neurology. https://doi.org/10.1016/s1474-4422(25)00227-3
Vancouver
Therriault J, Zetterberg H, Blennow K, Rosa-Neto P, et al. Blood phosphorylated tau for the diagnosis of Alzheimer's disease: a systematic review and meta-analysis. The Lancet Neurology. 2025. doi:10.1016/s1474-4422(25)00227-3. PMID: 40818474.
BibTeX
@article{therriault2025-1f9fdc81,
author = {Therriault, Joseph and Zetterberg, Henrik and Blennow, Kaj and Rosa-Neto, Pedro and others},
title = {{Blood phosphorylated tau for the diagnosis of Alzheimer's disease: a systematic review and meta-analysis}},
journal = {The Lancet Neurology},
year = {2025},
doi = {10.1016/s1474-4422(25)00227-3},
pmid = {40818474},
url = {https://doi.org/10.1016/s1474-4422(25)00227-3}
}
Built from the record alzhub holds for this paper, not looked up. Volume, issue and page numbers are not held in the record. The record's author list ends in “et al.”, so not every author is named. Check the citation against the original before you use it.
Key findings
- 113 studies, 29,625 participants included in bivariate meta-analysis
- p-tau217: 88.1% sensitivity, 88.7% specificity, 91.1% AUROC (best performer)
- p-tau181: 80.5% sensitivity, 76.4% specificity, 81.5% AUROC
- About 90% of pooled studies were rated high risk of bias due to lack of predefined thresholds
Why it matters
Across 113 studies, blood p-tau217 identified Alzheimer's pathology about 88% of the time and outperformed other tau variants like p-tau181. The authors warn that about 90% of the pooled studies had a high risk of bias from lack of predefined thresholds, so the reported accuracy may be inflated.
New to this subject? Start with our plain-English guide: Blood tests & biomarkers →
Study details
- Study designmeta-analysis
- Participants29,625
- Effect sizep-tau217: 88.1% sensitivity, 88.7% specificity, 91.1% AUROC (best performer); p-tau181: 80.5% sensitivity, 76.4% specificity, 81.5% AUROC
- Evidence strengthModerate
Limitations
About 90% of the pooled studies were rated high risk of bias due to lack of predefined thresholds, per the authors' own assessment.
How this study scored 76/100
Published in a leading specialty journal, and it is a meta-analysis pooling many studies. Scored zero for indexed in PubMed because the record does not state it. We have no data on journal's citation record, times cited, citations per year, impact for its field and year, still being cited, senior author's track record, institution's track record, multicenter collaboration and free to read, so those were left out: it earned 47 of the 62 points we could judge it on, which is 76 out of 100.
| Component | Points | Why |
|---|---|---|
| Journal tier | 9 / 10 | Tier 2 — leading specialty journal (The Lancet Neurology) |
| Journal's citation record | — / 4 | No journal record from OpenAlex — left out of this score |
| Study design | 12 / 12 | A meta-analysis pooling many studies |
| Strength of evidence | 3 / 5 | Rated “moderate” in our summary |
| Peer-review validation | 10 / 10 | Peer-reviewed. Published as an article in a named peer-reviewed journal. |
| How recent | 4 / 5 | 2025 — within 3 year(s) of the newest study here |
| Sample size | 4 / 4 | 29,625 participants |
| Effect reported | 2 / 3 | Effect reported as a number, without an interval or test |
| Studied in people | 3 / 3 | Studied in people (participant count stated) |
| Randomized / blinded | 0 / 2 | A review of other studies — randomization is not credited here |
| Times cited | — / 7 | No citation count (not found in OpenAlex) — left out of this score |
| Citations per year | — / 5 | No citation count or no year — left out of this score |
| Impact for its field and year | — / 6 | No field-weighted citation impact (OpenAlex has none yet) — left out of this score |
| Cited by studies here | 0 / 6 | No other study in this library cites it |
| Still being cited | — / 4 | No yearly citation counts — left out of this score |
| Senior author's track record | — / 4 | Senior author's record not available — left out of this score |
| Institution's track record | — / 3 | No institution listed in OpenAlex — left out of this score |
| Multicenter collaboration | — / 3 | Institutions not listed — left out of this score |
| Indexed in PubMed | 0 / 2 | No PubMed ID and no DOI — scores zero (not stated in the record — scored 0) |
| Free to read | — / 2 | Access not recorded — left out of this score |
| Points | 47 / 62 | Scored on 11 of 20 parts. We have no data for the rest, so they are left out: 47 of the 62 points we could judge it on is 76 out of 100. |
| Total | 76 / 100 | — |
What each of these 20 components measures, and what this score is not →
Read the original
Free copy unknown: no free-copy check has an answer for this record yet. That does not mean it is paywalled.
Related
Studies in the library that share something with this one. The line above each title says what.
Related studies in Biomarkers from nearby years
Also tagged “phosphorylated”
733 studies in the library carry the topic tag “phosphorylated”; these are this study's neighbours in a fixed, alphabetical-by-hash tour of them, not the closest in content. All 733 tagged studies.